Toxoplasmosis in Cats: Transmission, Testing, and Public Health Concerns

Introduction

Toxoplasmosis is a globally distributed zoonotic disease caused by the obligate intracellular apicomplexan parasite Toxoplasma gondii. Felids, including the domestic cat (Felis catus), serve as the definitive hosts in which the parasite completes its sexual cycle and produces environmentally resistant oocysts [1, 2, 64]. The unique role of cats in the epidemiology of toxoplasmosis makes understanding feline infection dynamics essential for veterinary medicine and public health [3, 78]. This article provides a detailed examination of T. gondii transmission in cats, diagnostic approaches for feline infection, and the public health implications of oocyst shedding, with a focus on evidence from peer-reviewed literature.

Transmission Biology in Cats

Life Cycle and Oocyst Shedding

Cats become infected with T. gondii primarily through ingestion of tissue cysts in intermediate hosts (e.g., rodents, birds) or, less commonly, through ingestion of sporulated oocysts from the environment [35, 59, 99]. After ingestion, bradyzoites released from tissue cysts invade the intestinal epithelium and undergo a series of asexual (merogony) and sexual (gametogony) developmental stages within enterocytes [1, 71]. The sexual cycle culminates in the formation of unsporulated oocysts, which are shed in feces after a prepatent period of 3 to 10 days following tissue cyst ingestion [2, 64]. Oocyst shedding typically lasts 1 to 3 weeks, during which millions of oocysts can be excreted [4, 63]. Once shed, oocysts sporulate in the environment within 1 to 5 days under aerobic conditions, becoming infectious to intermediate hosts [5, 50].

The molecular mechanisms governing sexual commitment in T. gondii involve epigenetic reprogramming and transcriptional regulation by factors such as AP2XII-2 [76, 79]. Recent advances have enabled in vitro production of pre-sexual stages using feline intestinal organoids and retinal epithelial cells, providing tools to study the molecular basis of cat-restricted development [2, 64, 71].

Risk Factors for Feline Infection

Seroprevalence studies in cats worldwide reveal substantial variation based on geographic location, lifestyle, and management practices. Outdoor access and hunting behavior are consistently associated with higher seropositivity [6, 7, 4, 100]. In a study from Hong Kong, community cats had significantly higher seroprevalence than privately owned cats [6]. Similarly, stray cats in Brazil, Romania, and Thailand show elevated infection rates compared to owned cats [46, 72, 84]. Age is another important factor; seroprevalence increases with age, reflecting cumulative exposure [81, 89]. Male cats may have higher seroprevalence in some populations, though results are inconsistent [46, 100].

Dietary habits also influence infection risk. Cats fed raw meat or allowed to hunt are at greater risk of acquiring T. gondii [78, 82]. In contrast, exclusive feeding of commercial cooked diets reduces exposure [91]. Environmental contamination with oocysts is a key driver of infection in free-roaming cat populations [63, 73]. Spatial analysis in Brazil demonstrated clustering of seropositive cats in areas with high stray cat density [4, 100].

Transmission to Intermediate Hosts

After sporulation, oocysts can survive for months to years in soil, water, and on vegetation, facilitating transmission to a wide range of warm-blooded animals [5, 35, 59]. Oocyst ingestion is the primary route of infection for herbivores and omnivores, including livestock and humans [8, 9, 10, 11, 53, 65, 68, 95]. The role of cats in contaminating the environment is therefore central to the epidemiology of toxoplasmosis [3, 78]. Mathematical models have been developed to describe transmission dynamics, incorporating factors such as cat density, oocyst decay rates, and intermediate host exposure [5, 35, 50].

Diagnostic Testing for Feline Toxoplasmosis

Accurate diagnosis of T. gondii infection in cats is important for clinical management, epidemiological surveillance, and risk assessment. Diagnostic methods can be broadly categorized into serological, molecular, and parasitological techniques [12].

Serological Methods

Serology detects antibodies (IgG, IgM, or IgA) against T. gondii antigens and is the most commonly used approach for assessing exposure in cats [12, 81, 84]. Commercial enzyme-linked immunosorbent assays (ELISAs) and indirect fluorescent antibody tests (IFAT) are widely employed [13, 38, 72]. IgG antibodies indicate past or chronic infection, while IgM or IgA may suggest recent or active infection, though interpretation can be complicated by persistent IgM in some cats [12, 84].

A novel sandwich ELISA targeting T. gondii circulating fructose-1,6-bisphosphate aldolase (ALD) protein has been developed for detection of active infection in cats [38]. This method detects parasite antigen in serum, offering potential for distinguishing current from past infection. Another ELISA approach uses sporozoite-specific antigens to detect oocyst-induced infections [13, 39].

Molecular Methods

Polymerase chain reaction (PCR) assays provide high sensitivity and specificity for detecting T. gondii DNA in feline feces, blood, or tissues [14, 15, 61, 83]. Conventional PCR targeting the B1 gene or 529 bp repeat element is widely used [15, 92]. Real-time PCR (qPCR) allows quantification of parasite DNA and is particularly useful for monitoring oocyst shedding intensity [63, 98].

Isothermal amplification methods, such as loop-mediated isothermal amplification (LAMP) and recombinase-aided amplification (RAA), offer rapid, field-deployable alternatives to PCR [37, 44, 58, 67, 92, 98]. Colorimetric LAMP assays targeting the B1 and RE genes enable visual detection without specialized equipment [92]. A cross-priming amplification (CPA) technique combined with lateral flow strips has also been developed for rapid visual detection [37]. More recently, recombinase polymerase amplification (RPA) coupled with CRISPR/Cas9 has been explored for enhanced specificity [58].

Antisense PCR, a novel approach using primers complementary to the coding strand, has shown improved sensitivity for detecting T. gondii in domestic cats [14]. Digital PCR (dPCR) provides absolute quantification and has been applied for enhanced detection of perinatal infections [52].

Parasitological Methods

Microscopic examination of feces for oocysts remains a direct method for diagnosing active shedding, but sensitivity is limited due to intermittent shedding and morphological similarity to Hammondia hammondi oocysts [15, 73]. Flotation techniques using zinc sulfate or sucrose solutions are commonly employed [45, 73]. Molecular differentiation from H. hammondi is essential for accurate diagnosis, and PCR-based genotyping can distinguish the two species [15].

Comparison of Diagnostic Methods

Decision Tree for Feline Toxoplasmosis Testing

flowchart TD
    A[Cat with clinical signs or risk assessment] --> B{Test purpose?}
    B --> C[Exposure history]
    B --> D[Active infection / shedding]
    B --> E[Clinical diagnosis]
    C --> F["Serology: IgG ELISA/IFAT"]
    F --> G["Positive: past exposure"]
    F --> H["Negative: no exposure"]
    D --> I[Fecal PCR or LAMP]
    I --> J["Positive: active oocyst shedding"]
    I --> K["Negative: no shedding detected"]
    D --> L[Sandwich ELISA for ALD antigen]
    L --> M["Positive: active infection"]
    L --> N["Negative: no active infection"]
    E --> O[Blood PCR + serology]
    O --> P["PCR positive + IgM/IgA: acute toxoplasmosis"]
    O --> Q["PCR negative + IgG: chronic infection"]
    O --> R["All negative: other etiology"]

Public Health Concerns

Zoonotic Transmission from Cats

Cats are the only definitive hosts that shed T. gondii oocysts into the environment, making them a critical source of infection for humans and other animals [3, 78]. Humans typically acquire toxoplasmosis through ingestion of sporulated oocysts from contaminated soil, water, or food, or through consumption of undercooked meat containing tissue cysts [8, 49, 68]. Direct contact with cats is not considered a major risk factor for human infection, as freshly shed oocysts require 1-5 days to sporulate and become infectious [16, 75]. However, handling of cat litter boxes or gardening in soil contaminated with cat feces poses a risk if proper hygiene is not observed [17, 18, 82].

Risk to Immunocompromised Individuals and Pregnant Women

Toxoplasmosis is of particular concern for immunocompromised individuals (e.g., organ transplant recipients, HIV patients) and pregnant women, in whom primary infection can lead to severe disease or congenital transmission [19, 20, 54, 93]. Seronegative pregnant women are advised to avoid exposure to cat feces and to practice good hygiene [16, 48, 66]. Studies in various countries have assessed knowledge and practices regarding toxoplasmosis among cat owners and pregnant women, revealing significant gaps in awareness [17, 18, 21, 36, 43, 69, 75, 82, 86, 91]. Veterinary professionals play a key role in educating cat owners about risk reduction [22, 82].

The "Fatal Feline Attraction" Phenomenon

T. gondii has been reported to alter the behavior of infected intermediate hosts, including rodents, potentially increasing their susceptibility to predation by cats [3]. This manipulation, sometimes termed "fatal feline attraction," is hypothesized to enhance parasite transmission to the definitive host. The evolutionary implications and clinical applications of this phenomenon remain an active area of research [3].

Environmental Contamination and One Health

Oocyst contamination of soil and water is a major public health concern, particularly in areas with large populations of free-roaming cats [4, 45, 63, 73]. Studies have detected T. gondii DNA in cat feces from urban and rural environments worldwide [15, 41, 63, 73]. The parasite has also been found in wildlife, including birds, deer, and marine mammals, indicating widespread environmental dispersal [23, 24, 25, 33, 34, 47, 51, 57, 59, 70, 77, 94, 97]. A One Health approach integrating veterinary, environmental, and public health sectors is essential for effective toxoplasmosis control [26, 49, 68].

Prevention and Control in Cats

Management Practices

Reducing the risk of T. gondii infection in cats involves limiting access to intermediate hosts (e.g., keeping cats indoors), feeding only cooked or commercial diets, and preventing scavenging [78, 82, 91]. Regular cleaning of litter boxes (daily) and proper disposal of cat feces minimize oocyst accumulation and sporulation [16, 75]. Pregnant women and immunocompromised individuals should avoid handling cat litter if possible [16, 48].

Vaccination

Vaccination of cats against toxoplasmosis could reduce oocyst shedding and environmental contamination. A live-attenuated T. gondii PruΔpp2a-c mutant has been shown to induce protective immunity and reduce oocyst shedding in cats [27]. Other vaccine strategies under investigation include mRNA vaccines and antigen discovery approaches targeting oocyst and cyst stages [26, 87]. However, no commercial feline toxoplasmosis vaccine is currently available.

Antiprotozoal Treatment

Treatment of acute toxoplasmosis in cats typically involves clindamycin or trimethoprim-sulfonamide combinations, but these drugs do not eliminate the chronic tissue cyst stage [12, 61]. Treatment during the oocyst shedding period may reduce the duration and magnitude of shedding, but efficacy is variable [12].

Conclusion

Toxoplasma gondii infection in cats is a complex biological and epidemiological issue with significant implications for veterinary practice and public health. The cat's role as the definitive host makes it central to the parasite's life cycle and environmental dissemination. Advances in diagnostic methods, including molecular assays and antigen detection, have improved our ability to detect active infection and oocyst shedding. Public health efforts must focus on educating cat owners about risk reduction and promoting responsible pet ownership. Continued research into feline transmission biology, vaccine development, and environmental surveillance is essential for reducing the burden of toxoplasmosis in both animal and human populations.

References

[1] Sena F, Hakimi M-A, Francia ME. Proliferating toward sex: characterization of cell division of Toxoplasma gondii's pre-sexual stages. mBio. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42153709/

[2] Cancela S, Sena F, Pagotto R, et al. Enhancing pre-sexual and sexual differentiation of Toxoplasma gondii using retinal epithelial cells and intestinal organoids. Cell Rep. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41108686/

[3] Webster JP. Who makes the decisions? Uncovering the evolutionary implications and clinical applications of Toxoplasma gondii's Fatal Feline Attraction. Folia Parasitol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40458021/

[4] Murata FHA, Barboza JP, Tasso FF, et al. Prevalence and spatial distribution of Toxoplasma gondii infection in domestic and stray cats (Felis catus) in Northwestern São Paulo, Brazil. Spat Spatiotemporal Epidemiol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40935507/

[5] Asif M, Popa IL, Ismail EAA, et al. Fractional-order mathematical modeling of toxoplasmosis transmission dynamics with harmonic mean-type incidence rate. Sci Rep. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40413236/

[6] Elsohaby I, Zubair M, Baqar Z, et al. Seroprevalence of Toxoplasma gondii and associated demographic factors in privately-owned dogs, cats, and community cats in Hong Kong. BMC Vet Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42135800/

[7] Bazan L, Argibay HD, Borges-Silva W, et al. Seroprevalence and risk factors for Toxoplasma gondii infection in wild, domestic and companion animals in urban informal settlements from Salvador, Brazil. PLoS Negl Trop Dis. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41401226/

[8] Muhammad AS, Kudi AC, Mohammed A, et al. Public health significance of prevalence and risk factors associated with Toxoplasma gondii infection in goats sampled from two quarantine facilities and an institutional farm in Maiduguri metropolis, Borno state, Nigeria. Sci Rep. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42020619/

[9] Hanedan B, Taş BZ, Yıldırım E, et al. Investigation of Toxoplasma gondii seroprevalence and associated risk factors in dairy cattle in the Eastern Anatolia region of Türkiye. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41819961/

[10] Alani AAJ, Omar TM. Epidemiology and Risk Factors of Ovine Toxoplasmosis: Evidence from a Cross-Sectional Study in Iraq. Acta Parasitol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41148433/

[11] Muftić A, Omeragić J, Fejzić N, et al. Seroepidemiology of porcine toxoplasmosis: A cross-sectional study in Bosnia and Herzegovina. Vet Med Sci. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40650964/

[12] Zhao D, Liao Y, Liu H, et al. Comprehensive diagnostic approaches to feline toxoplasmosis: Bridging traditional methods and emerging technologies. Virulence. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40974007/

[13] He M, Zhang B, Han S, et al. Development and optimization of an ELISA method to detect Toxoplasma gondii oocyst infection in cats. Parasitol Res. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40619535/

[14] Li YY, Bai SY, Yu HQ, et al. Development and evaluation of an antisense PCR assay for Toxoplasma gondii detection in domestic cats. Vet Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41724116/

[15] Jańczak D, Stryjek R, Maj AK, et al. PCR Detection, Genotyping, and Differentiation of Toxoplasma gondii from Hammondia hammondi Excreted in the Feces of Cats in Poland Between 2020 and 2024. Pathogens. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40430763/

[16] Gharbi M, Yera H, Dupouy-Camet J. [The cat, the women and the toxoplasma: What advice should be given to a pregnant woman who is seronegative for toxoplasmosis and owns a cat?]. Gynecol Obstet Fertil Senol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41628830/

[17] Henriette BA, Jémima EK, Jean-Sébastien MA, et al. First report of knowledge and practices towards toxoplasmosis among pregnant women in primary care in Abidjan, Côte d'Ivoire. Trop Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42199683/

[18] Chalabi KN, Jabar Bakr E. Toxoplasmosis - knowledge among university students in Erbil, Iraq: a cross-sectional study. Int J Environ Health Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41873025/

[19] Mihaljević D, Sitaš Z, Hanulak J, et al. Cerebral Toxoplasmosis in a Renal Transplant Recipient-A Rare Complication. Life (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41900989/

[20] Zheng X, Li J, Li Z, et al. The prevalence and associated risk factors of post-transplant Toxoplasma gondii infection among kidney transplant recipients and patients with uremia in Central-southern China. PLoS Negl Trop Dis. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40446014/

[21] Laboudi M, Sanaa AH. Assessment of the knowledge and awareness of toxoplasmosis among doctors and nurses in Casablanca, Morocco: a cross-sectional study. Pan Afr Med J. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40322325/

[22] Gamboa-Prieto J, Sánchez-Otero MG, Sánchez-Montes S, et al. SEROPREVALENCE OF TOXOPLASMA GONDII

[23] Aziz KJ, Mikaeelb FB, Nasrullah OJ, et al. Seroepidemiological investigation of Toxoplasma gondi and Neospora caninum in local Deers in Erbil, Iraq. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42034957/

[24] Didkowska A, Kołodziej-Sobocińska M, Matusik K, et al. Toxoplasma gondii in wild felides in Poland. BMC Vet Res. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41387866/

[25] Kołodziej-Sobocińska M, Holec-Gąsior L, Ferra B, et al. A long-term serological survey of Toxoplasma gondii in European bison (Bison bonasus) - the largest european herbivore. Vet Res Commun. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41359089/

[26] Qadeer A, Tharwat M, Khan MZ, et al. Advances and Translational Challenges in Toxoplasma gondii Vaccine Development: From Antigen Discovery to mRNA and One Health Strategies. Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42188907/

[27] Xie SC, Lv YH, Wang M, et al. Live-attenuated Toxoplasma gondii PruΔpp2a-c mutant elicits protective immunity against toxoplasmosis in mice and cats. Int J Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/40783178/

[28] Chen XX, Sun H, Liang Y, et al. Development of a SAG1-based colloidal gold immunochromatographic strip for rapid serological detection of swine Toxoplasma gondii. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42169035/

[29] Zhai B, Bao B, Xie SC, et al. Dynamic landscape of microRNA expression in the feline small intestine during Toxoplasma gondii infection. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41965856/

[30] Tahita MC, Kaboré B, Ilboudo H, et al. Toxoplasma gondii seroprevalence and associated factors among pregnant women attending their first antennal care visit in rural Burkina Faso. J Parasit Dis. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40901422/

[31] Khosravi S, Hajipour N, Moosavy MH, et al. Survival Rate of Toxoplasma gondii Tachyzoites in Cow's Milk at Different Temperatures. Vet Med Sci. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40884309/

[32] Bahadori A, Babazadeh T, Chollou KM, et al. Seroprevalence and risk factors associated with toxoplasmosis in nomadic, rural, and urban communities of northwestern Iran. Front Public Health. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40270728/

Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.